| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,557 |
Update - Dividend/Distribution - COH
|
23 Mar 2026 8:53AM |
$164.620 |
$100.260 |
fallen by
39.10%
|
|
| Sportshero Limited (SHO) ORDINARY FULLY PAID |
Communication Services |
$62 |
Change of registered office
|
23 Mar 2026 8:53AM |
$0.110 |
$0.069 |
fallen by
37.27%
|
|
| Felix Gold Limited (FXG) ORDINARY FULLY PAID |
Materials |
$126 |
Receipt of Bulk Sample Permit from Alaska DNR
|
23 Mar 2026 8:51AM |
$0.230 |
$0.255 |
risen by
10.87%
|
|
FXG - Price-sensitive ASX Announcement
Full Release
Key Points
- Felix Gold receives bulk sample permit from Alaska DNR.
- Permit allows extraction of 1,600 tons of stibnite ore.
- Permit valid until December 31, 2029.
- The project targets high-grade antimony supply for the U.S.
- Operations to start soon with equipment mobilization underway.
- Aims to reduce dependency on Chinese antimony imports.
- The ore grade is 89.2% antimony-bearing minerals.
- Project supports low-impact and low-cost development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Humm Group Limited (HUM) ORDINARY FULLY PAID |
Financials |
$323 |
Update on the Credit Corp proposal
|
23 Mar 2026 8:51AM |
$0.725 |
$0.640 |
fallen by
11.72%
|
|
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$93 |
Update - Notification of buy-back - ARA
|
23 Mar 2026 8:49AM |
$0.495 |
$0.480 |
fallen by
3.03%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,948 |
Update - Notification of buy-back - GYG
|
23 Mar 2026 8:47AM |
$16.930 |
$19.240 |
risen by
13.64%
|
|
| Genesis Energy Limited (GNE) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$2,644 |
Completion of Shortfall Bookbuild
|
23 Mar 2026 8:47AM |
$1.855 |
$2.020 |
risen by
8.89%
|
|
GNE - Price-sensitive ASX Announcement
Full Release
Key Points
- Genesis Energy Limited completed the shortfall bookbuild of a NZ$300 million underwritten rights offer.
- The clearing price was NZ$2.22 per share, a NZ$0.17 premium over the application price of NZ$2.05.
- Settlement for the ASX is on 24 March 2026 and for the NZX on 25 March 2026.
- Approximately NZ$400 million was raised in total, including a NZ$100 million placement.
- Genesis Energy Limited is a major New Zealand energy company with diverse assets and significant customer base.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$28,700 |
Update - Notification of buy-back - ALL
|
23 Mar 2026 8:46AM |
$45.270 |
$47.590 |
risen by
5.12%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$25 |
Cortexa advances commercialisation of MDMA supply
|
23 Mar 2026 8:44AM |
$0.038 |
$0.038 |
fallen by
0%
|
|
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$655 |
Weekly NTA Estimate
|
23 Mar 2026 8:40AM |
$2.800 |
$2.860 |
risen by
2.14%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$30,546 |
Notification of cessation of securities - BXB
|
23 Mar 2026 8:39AM |
$22.350 |
$22.660 |
risen by
1.39%
|
|
| Adisyn Ltd (AI1) ORDINARY FULLY PAID |
Information Technology |
$203 |
Webinar on Graphene Materials for UAV Defence Systems
|
23 Mar 2026 8:37AM |
$0.048 |
$0.195 |
risen by
306.25%
|
|
| Dimensional Australian Core Equity (Managed Fund) (DACE) |
Financials |
$6,412 |
Distribution Timetable Announcement
|
23 Mar 2026 8:37AM |
$17.760 |
$18.280 |
risen by
2.93%
|
|
| Dimensional Australian Value Trust - Active ETF (DAVA) |
Financials |
$1,402 |
Distribution Timetable Announcement
|
23 Mar 2026 8:37AM |
$31.370 |
$31.310 |
fallen by
0.19%
|
|
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$315 |
Update - Notification of buy-back - PAC
|
23 Mar 2026 8:36AM |
$9.750 |
$10.880 |
risen by
11.59%
|
|
| Hazer Group Limited (HZR) ORDINARY FULLY PAID |
Materials |
$95 |
KBR Engaged to Fast-Track Canada
|
23 Mar 2026 8:35AM |
$0.365 |
$0.355 |
fallen by
2.74%
|
|
| DeSoto Resources Limited (DES) ORDINARY FULLY PAID |
Materials |
$40 |
Change in substantial holding
|
23 Mar 2026 8:34AM |
$0.140 |
$0.145 |
risen by
3.57%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,829 |
Update - Notification of buy-back - DNL
|
23 Mar 2026 8:31AM |
$2.990 |
$3.320 |
risen by
11.04%
|
|
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$245 |
Change of Director's Interest Notice - J Welborn
|
23 Mar 2026 8:31AM |
$0.305 |
$0.320 |
risen by
4.92%
|
|
| Minerals 260 Limited (MI6) ORDINARY FULLY PAID |
Materials |
$1,754 |
FIRB Approval Received for Final $95M Royalty Payment
|
23 Mar 2026 8:30AM |
$0.615 |
$0.775 |
risen by
26.02%
|
|
MI6 - Price-sensitive ASX Announcement
Full Release
Key Points
- FIRB approval received for Franco-Nevada's $95 million payment.
- Completion of a $220 million strategic funding package.
- Bullabulling Gold Project hosts 4.5 million ounces of gold.
- Located 65km from Kalgoorlie, Western Australia.
- Funding to accelerate development and exploration strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cleo Diagnostics Ltd (COV) ORDINARY FULLY PAID |
Health Care |
$83 |
CLEO Optimises Biomarker Panel Ahead of FDA Submission
|
23 Mar 2026 8:29AM |
$0.480 |
$0.605 |
risen by
26.04%
|
|
COV - Price-sensitive ASX Announcement
Full Release
Key Points
- Biomarker panel expanded from five to eight biomarkers.
- Enhancement aims to improve analytical robustness, reproducibility, and manufacturability.
- Panel designed for the Ella™ platform to support high throughput.
- Partnership with experienced manufacturer for kit production.
- Milestone towards FDA 510(k) submission and commercial readiness.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LCL Resources Limited (LCL) ORDINARY FULLY PAID |
Materials |
$10 |
Rio Tinto to Farm-in to the Ono Project
|
23 Mar 2026 8:28AM |
$0.007 |
$0.008 |
risen by
23.08%
|
|
LCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Rio Tinto to make A$1.5 million cash payments to LCL.
- Initial Earn-In allows Rio Tinto to gain 51% interest by spending A$8 million.
- Further Earn-In option for Rio Tinto to increase interest to 80%.
- Ono Project located in Papua New Guinea, targeting copper-gold deposits.
- LCL retains significant exposure to potential exploration success.
- Agreement includes minimum exploration and drilling requirements.
- LCL to manage the project initially, with Rio Tinto having management rights.
- Conditional on obtaining necessary PNG government approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ARN Media Limited (A1N) ORDINARY FULLY PAID |
Communication Services |
$83 |
Legal proceedings commenced by Mr Sandilands
|
23 Mar 2026 8:27AM |
$0.330 |
$0.265 |
fallen by
19.70%
|
|
A1N - Price-sensitive ASX Announcement
Full Release
Key Points
- Legal proceedings commenced by Mr Kyle Sandilands against ARN Media Limited.
- Proceedings filed in the Federal Court against ARN and its subsidiary, Commonwealth Broadcasting Corporation Pty Ltd.
- Allegations include invalid termination of Mr Sandilands' contract and unconscionable conduct under Australian Consumer Law.
- Applicants seek specific performance, payment of amounts due, and damages.
- ARN disputes the claims and intends to defend the proceedings.
- Early stage of the matter with no reliable estimate of outcome or financial impact.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nexsen Limited (NXN) ORDINARY FULLY PAID |
Health Care |
$18 |
FDA feedback derisks US approval pathway for StrepSure
|
23 Mar 2026 8:26AM |
$0.160 |
$0.190 |
risen by
18.75%
|
|
NXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of a Pre-Submission meeting with FDA for StrepSure.
- FDA feedback supports Nexsen's regulatory strategy for StrepSure.
- A clearer and lower-risk pathway to U.S. market authorization for StrepSure.
- Significant milestone for Nexsen's first product in the FDA pathway.
- Early validation of Nexsen's broader platform for rapid diagnostics.
- Potential commercial impact in the maternal health market.
- StrepSure offers a rapid point-of-care test for Group B Streptococcus in pregnant women.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$3,722 |
Change of Director's Interest Notice - D Goodin
|
23 Mar 2026 8:25AM |
$28.080 |
$26.230 |
fallen by
6.59%
|
|
Call 1300 880 160
Start a chat
Schedule a call
